VSee Health, Inc. Operating Costs and Expenses
VSee Health, Inc. (VSEE) reported Operating Costs and Expenses of $2.59 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-12.
Discontinued › Operating Expenses
us-gaap:OperatingCostsAndExpenses · last filed 2024-04-12
- VSee Health, Inc. operating costs and expenses for the quarter ending 2023-12-31 was $925.66K, a 22.88% decline year-over-year.
- VSee Health, Inc. operating costs and expenses for the quarter ending 2023-09-30 was $518.08K, a 54.13% decline year-over-year.
- VSee Health, Inc. operating costs and expenses for the quarter ending 2023-06-30 was $442.43K, a 38.74% decline year-over-year.
- VSee Health, Inc. operating costs and expenses for the quarter ending 2023-03-31 was $707.59K, a 30.27% increase year-over-year.
- VSee Health, Inc. operating costs and expenses for fiscal 2023 was $2.59M, a 27.85% decline from fiscal 2022.
- VSee Health, Inc. operating costs and expenses for fiscal 2022 was $3.59M.
| Period end | Operating Costs and Expenses 3 month | Operating Costs and Expenses 4 month | Operating Costs and Expenses 6 month | Operating Costs and Expenses 7 month | Operating Costs and Expenses 9 month | Operating Costs and Expenses 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $925.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $1.44M derived: sum of 2 quarters · filed 2024-04-12 | $1.89M derived: sum of 3 quarters · filed 2024-04-12 | $2.59M 10-K · filed 2024-04-12 | ||
| 2023-09-30 | $518.08K 10-Q · filed 2023-11-20 | $960.51K derived: sum of 2 quarters · filed 2023-11-20 | $1.67M 10-Q · filed 2023-11-20 | $2.87M derived: sum of 4 quarters · filed 2024-04-12 | ||
| 2023-06-30 | $442.43K 10-Q · filed 2023-08-21 | $1.15M 10-Q · filed 2023-08-21 | $2.35M derived: sum of 3 quarters · filed 2024-04-12 | $3.48M derived: sum of 4 quarters · filed 2024-04-12 | ||
| 2023-03-31 | $707.59K 10-Q · filed 2023-05-15 | $1.91M derived: sum of 2 quarters · filed 2024-04-12 | $3.04M derived: sum of 3 quarters · filed 2024-04-12 | $3.76M derived: sum of 4 quarters · filed 2024-04-12 | ||
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $2.33M derived: sum of 2 quarters · filed 2024-04-12 | $3.05M derived: sum of 3 quarters · filed 2024-04-12 | $3.59M 10-K · filed 2024-04-12 | ||
| 2022-09-30 | $1.13M 10-Q · filed 2023-11-20 | $1.85M derived: sum of 2 quarters · filed 2023-11-20 | $2.39M 10-Q · filed 2023-11-20 | |||
| 2022-06-30 | $722.16K 10-Q · filed 2023-08-21 | $1.27M 10-Q · filed 2023-08-21 | ||||
| 2022-03-31 | $543.18K 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | $282.67K 10-K · filed 2023-04-12 | |||||
| 2021-09-30 | $180.00 10-Q · filed 2022-11-10 | $5.18K derived: sum of 2 quarters · filed 2022-11-10 | $5.18K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-15 | $5.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |